Are urinary 3‑ and 4‑methylhippuric acids and phenylglyoxylic acid biomarkers of xylene, ethylbenzene, and styrene exposure and does their metabolism increase hepatic biotransformation demand and oxidative stress leading to liver injury?

The metabolism of aromatic solvents such as xylene, ethylbenzene, and styrene involves complex hepatic biotransformation pathways that produce specific urinary metabolites. These compounds are extensively used as industrial solvents and are common environmental pollutants found in tobacco smoke and vehicle emissions.

Biomarker evidence

Urinary methylhippuric acids and phenylglyoxylic acid are validated tools for quantifying internal exposure to these hydrocarbons:

• Xylene Exposure: 3-methylhippuric acid (3-MHA) and 4-methylhippuric acid (4-MHA) are highly specific biomarkers for m-xylene and p-xylene. The American Conference of Governmental Industrial Hygienists (ACGIH) has established a Biological Exposure Index (BEI) of 1.5 g total MHA per gram of creatinine, which reflects exposure at the standard threshold limit value of 100 ppm.
• Ethylbenzene and Styrene Exposure: Phenylglyoxylic acid (PGA) serves as a terminal metabolite for both ethylbenzene and styrene. Because these solvents converge on the same metabolic pathway, PGA is typically measured alongside mandelic acid (MA) to assess the total body burden. Elevated levels of these metabolites have been associated with systemic effects, including decreased estimated glomerular filtration rate (eGFR) and increased fasting plasma glucose.

Mechanistic pathways and liver injury

The process of detoxifying these solvents places a significant burden on hepatic function and can initiate pathways of tissue damage:

• Hepatic Biotransformation Demand: These solvents are primarily metabolized by cytochrome P450 enzymes, particularly CYP2E1. Exposure induces increased enzymatic activity and microsomal demand, often evidenced by increased liver weight in toxicological models.
• Oxidative Stress Induction: The CYP450-mediated oxidation of aromatic hydrocarbons generates reactive oxygen species (ROS). This production can overwhelm cellular antioxidant defenses, specifically depleting glutathione levels, which are critical for maintaining redox balance.
• Pathogenesis of Liver Injury: Excess ROS lead to lipid peroxidation and mitochondrial dysfunction. These mechanisms are key drivers of inflammation and the progression of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) through the activation of pathways such as NADPH oxidase (NOX).

Bottom line

Urinary methylhippuric acids and phenylglyoxylic acid are scientifically validated biomarkers for xylene, ethylbenzene, and styrene exposure. The hepatic metabolism of these solvents increases biotransformation demand and triggers oxidative stress, which are established mechanistic contributors to liver injury and metabolic dysfunction.